A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the safety of decitabine in patients with
acute lymphocytic leukemia. Upon agreement of the patient, additional blood and bone marrow
samples to be used to evaluate the effect of the treatment on leukemic cells. Also, with
agreement of the patient, any leftover blood and bone marrow samples that are collected at
the start of the study and during the regularly scheduled evaluations to be sent for research
studies. The research studies will examine changes in the blood and bone marrow cells that
might help explain the causes of leukemia.